Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  atorvastatin calcium
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-9 of 9 for your search:
Start Over
Phase II Study of Atorvastatin Safety and Antitumor Effects in Non-Hodgkin's Lymphoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: Over 18
Sponsor: Other
Protocol IDs: LYMNHL0020, 4328-07, 95140, 13683, NCT00185731
Atorvastatin Calcium, Oligofructose-Enriched Inulin, or Sulindac in Preventing Cancer in Patients at Increased Risk of Developing Colorectal Neoplasia
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 40 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00837, CDR0000467755, MAY03-1-03, N01CN35000, P30CA015083, MAYO-030103, MAYO-1395-05, NCT00335504
Zoledronate With Atorvastatin in Renal Cell Carcinoma
Phase: Phase II
Type: Supportive care
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: 2005-0652, NCT00490698
Study of Statin as Neo-Adjuvant Therapy in Postmenopausal Breast Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Over 18
Sponsor: Other
Protocol IDs: MAST1, EudraCT number: 2008-005863-32, NCT00816244
Atorvastatin Calcium and Celecoxib in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 080811, 0220090006, NCI-2012-00540, CINJ-080811, NCT01220973
Safety & Efficacy of Atorvastatin for Prophylaxis of Acute Graft Versus Host Disease in Patients With Hematological Malignancies HLA- Donor Hematopoietic Stem Cell Transplantation
Phase: Phase II
Type: Supportive care
Status: Closed
Age: 18 to 75
Sponsor: Other
Protocol IDs: OSU-11004, NCI-2011-03590, NCT01491958
Statin Therapy in Young Adult Survivors of Childhood Cancer
Phase: Phase II
Type: Supportive care
Status: Closed
Age: 18 to 39
Sponsor: Other
Protocol IDs: 1207M17202, NCT01733953
A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer
Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 18 to 72
Sponsor: NCI
Protocol IDs: NCI-2009-00859, CDR0000653466, 2006-0185, MDA05-6-01, N01CN35159, P30CA016672, MDA-MDA05-6-01, MDA-2006-0185, NCT00637481
A Phase 1 Study to Evaluate the Effects of Fluconazole and Atorvastatin on the Pharmacokinetics of TAK-385 in Healthy Subjects
Phase: Phase I
Type: Biomarker/Laboratory analysis
Status: Completed
Age: 18 to 55
Sponsor: Pharmaceutical / Industry
Protocol IDs: C27005, NCT02093390
Start Over